CXXI — C21 Investments Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for C21 Investments, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

	2019 January 31st	2020 January 31st	R2021 January 31st	2022 January 31st	2023 January 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2.59	37.7	33.5	33	28.9
Cost of Revenue
Gross Profit	0.183	13.3	18	18.8	13.4
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	24.7	67.3	24.2	23.2	25
Operating Profit	-22.2	-29.6	9.24	9.75	3.93
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-23.6	-28.8	-1.63	17.1	4.19
Provision for Income Taxes
Net Income After Taxes	-23.6	-32.6	-4.6	13.2	1.38
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-23.6	-32.6	-7.83	10.9	0.293
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-23.6	-32.6	-7.83	10.9	0.293
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.431	-0.184	-0.044	0.109	0.011